Next Oncology

Clinical research site in Houston, Texas · 4782 BEECHNUT ST, HOUSTON, TX 77096-1637 · (713) 349-8200 · Website

Part of NEXT Oncology

As of July 2026, 9 paid clinical trials are recruiting at Next Oncology in Houston, Texas. Active studies at this site cover conditions such as ER+, HER 2- Breast Cancer, Non-small Cell Lung Cancer (NSCLC) and Castration-resistant Prostate Cancer (CRPC). Compensation typically covers time, travel, and study visits — most studies also offer study-related medical care at no cost to participants.

Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: July 19, 2026.

Recruiting clinical trials at Next Oncology (9)

A Study to Investigate the Safety, Pharmacokinetics, and Preliminary Efficacy of IDE574 Therapy in Adult Participants With Advanced Solid Tumors

for ER+, HER 2- Breast Cancer

11 locations incl. Plantation

Sponsor: IDEAYA Biosciences

Sex: All·Age: 18 - 99

Code: NCT07540572·Phase 1·Recruiting·Listed Apr 2026

Apply to this trial

A Study of IDE034 in Adult Participants With Locally Advanced/Metastatic Solid Tumors Types

for Esophageal Squamous Cell Carcinoma

15 locations incl. Denver

Sponsor: IDEAYA Biosciences

Sex: All·Age: 18+

Code: NCT07503808·Phase 1·Recruiting·Listed Mar 2026

Apply to this trial

Open-Label Study to Evaluate the Safety, Tolerability, PK, and Efficacy of INX-315 in Patients With Advanced Cancer

for Breast Cancer

15 locations incl. Orlando

Sponsor: Incyclix Bio

Sex: All·Age: 18+

Code: NCT05735080·Phase 1, Phase 2·Recruiting·Listed Feb 2023

Apply to this trial

A Study of CUSP06 in Patients With Platinum-Refractory/Resistant Ovarian Cancer and Other Advanced Solid Tumors

for Ovarian Cancer

14 locations incl. Denver

Sponsor: OnCusp Therapeutics, Inc.

Sex: All·Age: 18+

Code: NCT06234423·Phase 1·Recruiting·Listed Jan 2024

Apply to this trial

A Study of NEOK002, an EGFR and MUC1 Targeting Bispecific ADC, in Participants With Select Solid Tumors

for Locally Advanced (Unresectable) or Metastatic Solid Tumors

8 locations incl. New York

Sponsor: NEOK Bio, Inc.

Sex: All·Age: 18+

Code: NCT07612189·Phase 1·Recruiting·Listed May 28, 2026

Apply to this trial

A Phase 1 Study of NEOK001, a B7-H3 and ROR1 Targeting Bispecific ADC in Participants With Select Solid Tumors

for Locally Advanced (Unresectable) or Metastatic Solid Tumors

8 locations incl. New York

Sponsor: NEOK Bio, Inc.

Sex: All·Age: 18+

Code: NCT07612176·Phase 1·Recruiting·Listed May 28, 2026

Apply to this trial

Phase 1/2 Study of UI-102 in Selected Advanced Cancers

for Advanced Cancer

3 locations incl. Dallas

Sponsor: United Immunity, co., Ltd.

Sex: All·Age: 18+

Code: NCT07605962·Phase 1, Phase 2·Recruiting·Listed May 26, 2026

Apply to this trial

Study of the Kinesin Oral Molecular Degrader BBI-940 in Subjects With Advanced or Metastatic Breast Cancer

for Breast Cancer

8 locations incl. Los Angeles

Sponsor: Boundless Bio, Inc.

Sex: All·Age: 18+

Code: NCT07408089·Phase 1·Recruiting·Listed Feb 2026

Apply to this trial

A Study to Evaluate the Safety and Efficacy of MK-3120 in Participants With Advanced Solid Tumors (MK-3120-002)

for Advanced Solid Tumors

7 locations incl. Birmingham

Sponsor: Merck Sharp & Dohme LLC

Sex: All·Age: 18+

Code: NCT06818643·Phase 1, Phase 2·Recruiting·Listed Feb 2025

Apply to this trial

More research sites in Houston

MD Anderson Cancer Center (422 trials)
M D Anderson Cancer Center (272 trials)
Baylor College of Medicine (197 trials)
The University of Texas Health Science Center at Houston (185 trials)
The University of Texas MD Anderson Cancer Center (131 trials)
Houston Methodist Hospital (128 trials)
Texas Children's Hospital (113 trials)
The University of Texas M. D. Anderson Cancer Center (85 trials)
University of Texas MD Anderson Cancer Center (83 trials)
UT MD Anderson Cancer Center (62 trials)

Explore more

Paid clinical trials in Houston, TX · Texas clinical trials